Supply chain transparency

Facing the challenge of performing a comprehensive global supply chain audit, head on.

pfizerbrown

Pfizer Inc (Pfizer) discovers, develops, manufactures, and commercializes biopharmaceuticals. The company offers products to treat various conditions such as cardiovascular, metabolic and pain, women’s health, cancer, inflammation, immune disorders, and rare diseases. It also provides sterile injectable pharmaceuticals, biosimilars, active pharmaceutical ingredients (APIs) and contract manufacturing services.

Pfizer sells its products through wholesalers, retailers, hospitals, individual provider offices, clinics, government agencies and pharmacies. It has major manufacturing facilities in India, China, Japan, Ireland, Italy, Belgium, Germany, Singapore, and the US. The company provides its products in North America, South America, Asia-Pacific, Australia, Europe, Africa, and the Middle East. Pfizer is headquartered in New York, the US.

The Challenge

Pfizer’s corporate EHS group needed a global partner to develop, implement and execute a global supply chain audit program, to evaluate potential supply chain risks related to environmental performance and compliance at its contract manufacturers in the Americas, EMEA, APAC regions. This entailed conducting approximately 100 global audits in 18 months.

Pfizer needed a business partner well versed with Pharmaceutical Supply Chain Initiative (PSCI) audit protocols and Anti-Microbial Resistance (AMR) framework.

The Solution

The Catalyst Group worked with corporate EHS to develop, implement and execute global audits of their supply chain partners located in the Americas, EMEA and APAC regions.  This consisted of:

Engaging with Pfizer’s EHS group to define KPIs

Developing a customized audit plan

Assembling a globally qualified and diverse audit team

Execution of the audit program

Reporting & Analysis

Follow-up and continuous improvement

Expertly gathering, analyzing, and reporting on the essential data that drives your strategic decisions.

The Results

blank

100% Audit Completion Rate

blank

Significant supplier risk reduction

blank

40% reduction in audit costs compared to the prior solution

blank

Full transparency of environmental risks in Pfizer’s supply chain

blank

Increased audit quality and consistency

blank

Increased supplier engagement and feedback

blank

Join us in leading the transformation of industry towards sustainable Health, Safety, and the Environmental practices.

Let’s make a difference together.